Sleepwalking towards Canada’s next major health crisis
Canadians deserve better than all levels of government dishing blame at each other while nothing gets done about antimicrobial resistance.
Hill staffers look back on the COVID-19 pandemic from their front-row seats to history
In the second instalment of The Hill Times‘ retrospective on the fourth anniversary of the COVID-19 pandemic, staffers recall the behind-the-scenes anxiety, and the ‘golden age of Question Period.’
‘We still only have a fragmented picture’: new report on COVID response finds critical institutions exposed both strengths and weaknesses in the federal system
The report that takes a deep dive into Canada’s response to the COVID-19 pandemic calls for the appointment of an independent expert panel to do a thorough examination of how Canadian institutions performed during the biggest public health emergency of the last century.
Suicide prevention in military and RCMP communities: where do families fit in?
It is crucial that family members who play an important role in suicide prevention are not overlooked, but are provided with their own resources, tools and supports.
Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians
The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
‘May you govern in interesting times’: MPs, Senators look back on the COVID-19 pandemic and the day ‘everything changed’
With four years in the books since Canada’s Parliament shut down to deal with an emerging public health threat, and more than a year after the World Health Organization announced an official end to the global pandemic, Labour Minister Seamus O’Regan says no one is ‘over COVID.’
‘Baby-steps’ pharmacare a test of our humanity and of our political leaders
If the proposals survive, this national pharmacare intro-package should fill open gaps for many insulin-dependent diabetics, especially those with Type 1 diabetes. But there is scant hope of a full-fledged pharmacare program anytime soon.
Prescription for change: diversity’s missing link in Canada’s health-care system
If Canada were to deploy pharmacogenetic-guided treatments for patients with depression, we would save on average $3,000 per patient. If only 50 per cent of the 1.6 million Canadians with depression were treated based on this method, we would save $2.4-billion per year.
We have the power to prevent death for so many, so let’s do it
Canada can avert tragedies before they unfold by supporting access to HPV vaccination and screening worldwide through the financing of innovative global health initiatives.
‘A lot of outstanding detail’ on pharmacare leaves program’s future riding on talks with provinces
A patchwork of incomplete or dissimilar deals across the country could make the program ‘very vulnerable to just being killed by a government that wasn’t in favour of it,’ says access-to-medicines expert Michael Law.
